RELA and familial dilated cardiomyopathy: Molecular docking results also revealed that AKT1, VEGFA, MMP9, and RELA were promising potential targets for DCM treatment, consistent with the above results of PPI network analysis and immune mechanism analysis and verified the gene enrichment results.